SCHEMBL242996

SCHEMBL242996

CCCC(=O)c1ccc(Sc2ccccc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.66
HPGD P15428 3/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
ALDH1A1 P00352 1/20 0.59
HSD17B3 P37058 3/20 0.56
LMNA P02545 3/20 0.47
MAPT P10636 2/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NR4A2 P43354 1/20 0.46
STS P08842 1/20 0.45
RAB9A P51151 2/20 0.44
KMT2A Q03164 1/20 0.44
FFAR1 O14842 1/20 0.44
CYP1A2 P05177 1/20 0.44
HIF1A Q16665 1/20 0.44
HTR7 P34969 1/20 0.43
NPC1 O15118 1/20 0.42
THRA P10827 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195006 0.93 HSD17B3 (0.64) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10872418 0.90 HSD17B3 (0.59) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10874949 0.88 HSD17B3 (0.60) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL4419356 0.87 HSD17B3 (0.58) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10879508 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL243463 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10875468 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10877102 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10877296 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3
SCHEMBL10879487 0.87 HSD17B3 (0.61) L3MBTL1HPGDSMN1; SMN2ALDH1A1HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551962-A Composition comprising a fatty acid ester and a fatty acid ester 电化株式会社 2022-12-30 CN claimed
US-20250355352-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN LAYER USING THE SAME, DISPLAY DEVICE, AND MANUFACTURING METHOD OF PHOTOSENSITIVE RESIN LAYER SAMSUNG SDI CO LTD (KR) 2025-11-20 US disclosed
US-20250355355-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN LAYER USING THE SAME, DISPLAY DEVICE, AND MANUFACTURING METHOD OF PHOTOSENSITIVE RESIN LAYER SAMSUNG SDI CO LTD (KR) 2025-11-20 US disclosed
US-20250355351-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN LAYER USING THE SAME, DISPLAY DEVICE, AND MANUFACTURING METHOD OF PHOTOSENSITIVE RESIN LAYER SAMSUNG SDI CO LTD (KR) 2025-11-20 US disclosed
CN-118434814-A Pressure-sensitive adhesive sheet 日东电工株式会社 2024-08-02 CN disclosed
US-20240241438-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-18 US disclosed
EP-4394001-A1 REACTIVE DYE AND PHOTOSENSITIVE COMPOSITION USING SAME Duksan Neolux Co., Ltd (KR) 2024-07-03 EP disclosed
WO-2024101181-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN COATING FILM, PATTERN FORMATION METHOD, AND LIGHT EMITTING ELEMENT 信越化学工業株式会社 2024-05-16 WO disclosed
CN-117991588-A Photosensitive resin composition, photosensitive resin layer using same, color filter, and display device 三星SDI株式会社 2024-05-07 CN disclosed
WO-2024075586-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN COATING FILM, PATTERN FORMATION METHOD, AND LIGHT-EMITTING ELEMENT 信越化学工業株式会社 2024-04-11 WO disclosed
US-20050192384-A1 Additive composition for increasing the storage stability of ethylenically unsaturated resins CIBA SPECIALTY CHEMICALS CORP. 2005-09-01 US disclosed
US-20050175930-A1 Photosensitive resin composition for black matrix CHI MEI CORPORATION (TW) 2005-08-11 US disclosed
EP-1235863-B1 USE OF AN ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS CIBA SC HOLDING AG (CH) 2005-01-26 EP disclosed
CN-1570764-A Light-sensitive resin composition for black matrix CHI MEI CORP (CN) 2005-01-26 CN disclosed
US-6733847-B2 DEPOSITION OF ELECTRON- OR H-DONORS HAVING AT LEAST ONE ETHYLENICALLY UNSATURATED GROUP ON A PLASMA-ACTIVATED SUBSTRATE, CURING BY IONIZATION RADIATION OR ELECTROMAGNETIC ENERGY CIBA SPECIALTY CHEMICALS CORPORATION 2004-05-11 US disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 US disclosed
US-20030129322-A1 Process for the production of strongly adherent surface-coatings by plasma-activated grafting CIBA SPECIALTY CHEMICALS CORP. 2003-07-10 US disclosed
US-6548121-B1 Subjecting substrate to action of low-temperature plasma discharge or radiation, applying photoinitiator containing ethylenically unsaturated group, curing, depositing metal or oxide CIBA SPECIALTY CHEMICALS CORPORATION 2003-04-15 US disclosed
EP-1235863-A1 ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS Ciba SC Holding AG (CH) 2002-09-04 EP disclosed
WO-2001042313-A1 ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250355351-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN LAYER USING THE SAME, DISPLAY DEVICE, AND MANUFACTURING METHOD OF PHOTOSENSITIVE RESIN LAYER LCP1, CD79B, ARCN1 L3MBTL1 4465/4885HPGD 2934/4885SMN1; SMN2 3873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.